The Latest Cardiac and Vascular News
REDWOOD CITY, Calif.–(BUSINESS WIRE)– HeartFlow, Inc. today announced that it has entered into a collaborative research agreement with Imperial College London. The collaboration will enable experts from HeartFlow and Imperial to work side-by-side on joint projects in the areas of medical imaging and deep learning. The company’s non-invasive HeartFlow® FFRct Analysis leverages deep […]
ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, presented 18-month outcomes from its LIBERTY 360° study at the Cardiovascular Research Technologies (CRT) 2018 interventional cardiology conference in Washington, D.C. The […]
IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, announced today that the first patient was treated in the EVAS2 IDE Confirmatory Clinical Study of the investigational Nellix® EndoVascular Aneurysm Sealing (EVAS) System by Sajjad M. Hussain, M.D., Chief of the Department of Vascular Surgery […]
SAN FRANCISCO, March 5, 2018 /PRNewswire/ — Symic Bio, a biopharmaceutical company developing novel extracellular matrix targeting drugs, today announced results from a preclinical study of locally-applied therapeutic SB-030 in the reduction of inflammatory response and clot formation. In a porcine arteriovenous shunt model for vascular procedures such as bypass grafts and angioplasty, […]
Comprehensive informatics and imaging solution features enhanced security protocols to meet industry-leading standards Improved interoperability and standardization increases scalability across the hospital enterprise to help improve efficiency and quality AMSTERDAM and LAS VEGAS, March 5, 2018 /PRNewswire/ — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of IntelliSpace Cardiovascular 3.1, […]
WALTHAM, Mass.–(BUSINESS WIRE)– Corindus Vascular Robotics Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the first automated robotic movement designed for the CorPath GRX platform. The proprietary software feature, named “Rotate on Retract” […]
IRVINE, Calif.–(BUSINESS WIRE)– Nihon Kohden Corporation, a U.S. market leader in precision medical products and services, has launched its aireeg®WEE-1200 wireless electroencephalogram (EEG) system designed specifically for patient comfort and easy access to real-time patient data during long-term epilepsy monitoring, intensive care, and routine EEG environments. The smart, safe and secure […]
REDWOOD CITY, Calif., March 02, 2018 (GLOBE NEWSWIRE) — Avinger, Inc. (Nasdaq:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced it has regained compliance with Nasdaq listing requirements. In a letter dated March 1, 2018, Nasdaq informed the Company that it has achieved compliance with […]
NEWARK, Del.–(BUSINESS WIRE)–W. L. Gore & Associates today announced that Jason Field, global sales and marketing leader for Gore Medical Products Division, will succeed Terri Kelly in the role of President and CEO effective April 1, 2018. Terri Kelly will continue to serve on Gore’s Board of Directors through July 2018. […]
ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the OrbusNeich® 1.0mm Sapphire® II PRO coronary balloon. OrbusNeich’s […]
